Mammalian class I cysteine-based dual-specificity phosphatases (DSPs) constitute a broad family of protein tyrosine phosphatases (PTPs), both in number and diversity. PTP domain class I DSPs differ from classical PTPs in that they can dephosphorylate phospho-Tyr, phospho-Ser and phospho-Thr residues, as well as nonproteinaceous substrates, including signaling lipids and complex carbohydrates. DSPs are nontransmembrane proteins (with the exception of TPIP and TPTE) that contain a single catalytic domain, and their modular structure ranges from the 'minimal PTP core' of the small atypical DSPs to the multimodular structure of some large myotubularins. DSPs can be clustered in several groups that include MAP-kinase phosphatases (MKPs), myotubularins (MTMs), PTEN-related phosphatases, slingshots (SSHs), PRLs, CDC14s and a heterogenous group named atypical DSPs [1]. The involvement of some of these DSPs in human disease is well established, because their genes (PTEN, MTMs, laforin) are targeted by mutations in sporadic tumors or in the germline of patients with hereditary disorders. In addition, recent findings indicate that many other